Abbott Atrial Fibrillation Post Approval Study

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 21, 2022

Primary Completion Date

October 22, 2024

Study Completion Date

November 30, 2026

Conditions
Atrial ArrhythmiaAtrium; FibrillationAtrial Tachycardia
Interventions
DEVICE

electrophysiology study and ablation with an Abbott Ablation Catheter

During the cardiac ablation procedure, an ablation catheter (a thin, flexible tube that can be threaded through the blood vessels to the heart) will deliver radiofrequency energy (a type of heat) to one or more areas in the upper left chamber of the heart that is causing the irregular heartbeat. The tip of the catheter will transmit energy to one or more small spots of heart tissue. This energy creates a small scar on the heart. This scar will block the electrical pathway that is causing the rapid heartbeat

Trial Locations (20)

18901

Doylestown Hospital, Doylestown

23225

Chippenham Hospital, Richmond

23507

Sentara Norfolk General Hospital, Norfolk

30342

Northside Hospital, Atlanta

35801

Heart Center Research, LLC., Huntsville

37203

Centennial Medical Center, Nashville

37403

Erlanger Medical Center, Chattanooga

38801

North Mississippi Medical Center, Tupelo

48075

Providence Hospital, Southfield

59802

St. Patrick Hospital, Missoula

68198

University of Nebraska Medical Center, Omaha

70121

Ochsner Medical Center, New Orleans

72205

Arkansas Cardiology, Little Rock

73135

Oklahoma Heart Hospital South, Oklahoma City

78229

Methodist Hospital of San Antonio, San Antonio

84124

St. Marks Hospital, Salt Lake City

92270

Eisenhower Medical Center, Rancho Mirage

94062

Sequoia Hospital, Redwood City

02115

Brigham & Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT05434650 - Abbott Atrial Fibrillation Post Approval Study | Biotech Hunter | Biotech Hunter